Update your billing and coding systems to include the permanent CYRAMZA® (ramucirumab) J-code: J9308, injection, ramucirumab, 5 mg. Issued by the Centers for Medicare & Medicaid Services (CMS), this permanent J-code is effective as of January 1, 2016.

Update your billing and coding systems to include the permanent CYRAMZA® (ramucirumab) J-code: J9308, injection, ramucirumab, 5 mg. Issued by the Centers for Medicare & Medicaid Services (CMS), this permanent J-code is effective as of January 1, 2016.

 

Help your patients stay focused on treatment.
Not how to pay for it.

For some patients, especially those without insurance, facing the cost of cancer treatment may be almost as difficult as the diagnosis itself. When you prescribe a Lilly Oncology product, Lilly PatientOne provides a resource for access and reimbursement assistance. Through PatientOne you may be able to help your qualified patients get the assistance they need, allowing them to start treatment with one less worry.

Patient Access Specialists, available through PatientOne

Patient Access Specialists provide information and education to help you navigate the complex access and reimbursement landscape. We’re here to help make access to prescribed Lilly Oncology products easier for your patients.

To learn more, call 1-866-4PatOne (1-866-472-8663).